Ruyi Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- Circular RNAs in diseases 3
- Cancer-related gene regulation 3
- Natural product bioactivities and synthesis 3
- RNA modifications and cancer 3
-
- MicroRNA in disease regulation 3
- Co-authors
- Xueqiong Zhu (5 shared papers)Yizuo Song (7 shared papers)Yaxian Li (2 shared papers)Xibo Pei (3 shared papers)Yahong Li (1 shared paper)Qianbing Wan (2 shared papers)Junyu Chen (2 shared papers)Shu Zhang (1 shared paper)
- Journals
- Advanced Science (2 papers)Frontiers in Oncology (2 papers)Bioscience Reports (2 papers)Stem Cell Research & Therapy (1 paper)Biosensors and Bioelectronics (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ruyi Li
35 papers receiving 589 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 94
- Molecular Biology 255
- Clinical Biochemistry 20
- Complementary and alternative medicine 23
- Biological Psychiatry 6
Countries citing papers authored by Ruyi Li
This map shows the geographic impact of Ruyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyi Li more than expected).
Fields of papers citing papers by Ruyi Li
This network shows the impact of papers produced by Ruyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyi Li. The network helps show where Ruyi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruyi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 95 | |
| 2 | 2021 | 44 | |
| 3 | 2020 | 44 | |
| 4 | 2017 | 42 | |
| 5 | 2021 | 39 | |
| 6 | 2019 | 34 | |
| 7 | 2023 | 27 | |
| 8 | 2022 | 23 | |
| 9 | 2021 | 23 | |
| 10 | 2020 | 22 | |
| 11 | 2014 | 17 | |
| 12 | 2019 | 16 | |
| 13 | 2020 | 16 | |
| 14 | 2024 | 16 | |
| 15 | 2019 | 15 | |
| 16 | Atorvastatin suppresses the progression of cervical cancer via regulation of autophagy. | 2020 | 15 |
| 17 | 2019 | 13 | |
| 18 | 2018 | 12 | |
| 19 | 2024 | 11 | |
| 20 | 2024 | 10 |
About Ruyi Li
Ruyi Li is a scholar working on Molecular Biology, Cancer Research, Clinical Biochemistry, Genetics and Immunology, having authored 38 papers that have together received 598 indexed citations. Recurring topics across this work include Metal-Organic Frameworks: Synthesis and Applications (3 papers), Electrochemical Analysis and Applications (3 papers), Circular RNAs in diseases (3 papers), Advanced Glycation End Products research (3 papers), Cancer-related gene regulation (3 papers), Natural product bioactivities and synthesis (3 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (94 citations), Molecular Biology (255 citations), Clinical Biochemistry (20 citations), Complementary and alternative medicine (23 citations) and Biological Psychiatry (6 citations). Ruyi Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xueqiong Zhu, Yizuo Song, Xueqiong Zhu, Yaxian Li, Xibo Pei, Yahong Li, Qianbing Wan, Junyu Chen, Shu Zhang and Yuanyuan Li. Their work appears in journals such as Advanced Science, Frontiers in Oncology, Bioscience Reports, Stem Cell Research & Therapy and Biosensors and Bioelectronics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.